GlassScriptPhysician profile
Todd D Renschler
NPI 1972592681
$6,067.20
in general payments reported to CMS, 2019-2025
27 companies · $892 in 2025
The $892 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,509 · 2020: $249 · 2021: $335 · 2022: $459 · 2023: $1,034 · 2024: $588 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,350 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,349.60 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,449.54 | 2019-2020 | |
| Medtronic, INC. | $1,253.04 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $840.84 | 2019-2025 | Ams 700, General - Therapies, Moses |
| Edap Technomed INC | $396.83 | 2024-2025 | |
| Astellas Pharma US INC | $306.42 | 2019-2023 | |
| Teleflex LLC | $296.81 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $198.50 | 2020-2024 | Axonics |
| Cook Medical LLC | $160.09 | 2019-2023 | Fiber Dust |
| Laborie Medical Technologies Corp. | $148.89 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $132.00 | 2019 | |
| Janssen Biotech, INC. | $128.37 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $128.00 | 2023 | Aquabeam Robotic System |
| Abbvie INC. | $120.58 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $67.02 | 2019 | |
| Endo USA, INC. | $61.40 | 2025 | Xiaflex |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $60.38 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $59.56 | 2025 | Gemtesa |
| Neotract INC. | $45.39 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $40.67 | 2025 | |
| Accord Healthcare, INC. | $37.56 | 2025 | |
| Coloplast Corp | $36.73 | 2019-2021 | |
| Tolmar, INC. | $34.40 | 2025 | Jatenzo, Eligard |
| Amgen INC. | $16.23 | 2019 | |
| 180 Medical, INC. | $13.35 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Allergan, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Renschler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.